Proactive Investors - Run By Investors For Investors
Why invest in WRLD.U?
ICC International Cannabis Corp.: DEEP DIVE
OVERVIEW

ICC International Cannabis continuing with 'buy-and-build' strategy

The firm wants to become the first publicly listed, globally focused, pure cannabis company
ICC International Cannabis continuing with 'buy-and-build' strategy
OVERVIEW: WRLD.U The Big Picture
ICC believes it is a preeminent player in the evolving international cannabis realm

ICC International Cannabis Corp. (CSE: WRLD, OTC:KNHBF) updated on activity, saying it plans to continue with its 'buy-and-build' strategy over the next  12 months.

The firm is on a mission to become the first publicly listed, globally focused, vertically integrated, pure cannabis company and its cultivation licences already span four countries and three continents.

"Over the past eight months International Cannabis has undergone a transformational shift, demonstrated by the expansion of the company’s portfolio holdings," said Eugene Beukman, chief executive and director at the group.

"ICC believes it is a preeminent player in the evolving international cannabis realm and looks forward to further illustrating exciting developments in the coming weeks."

The company added that it continues to evaluate potential cannabis and CBD centric assets in a variety of high-growth jurisdictions, including, but not limited to, Uruguay, Portugal, Malta, Costa Rica, Seychelles, and Switzerland.

The firm outlined the following assets and licences:

Polannabis Holdings

Polannabis, through a subsidiary, controls a Polish hemp processing and extraction licence. The licence permits the extraction and manufacturing of cannabinoid-(CBD)-derived products from hemp.

Danavian Cannabis Ltd

This year, International Cannabis entered into a definitive agreement with Danavian Cannabis to acquire 100% of its shares and thus now controls one of 12-Cannabis cultivation and manufacturing licences in the Kingdom of Denmark.

Marathon Global Inc

In May, the firm agreed with Marathon Global Inc to acquire 50% of its issued and outstanding shares.#

Marathon Global has an exclusive agreement with Cosmos Holdings to procure and distribute medical Cannabis products and all Cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 110 clients, representing approximately 35,000 pharmacies in 16 countries.

CanAfrica Holdings

In June, the firm executed a share purchase agreement with CanAfrica Holdings to acquire 100% of the firm.

CanAfrica holds a licence to cultivate, manufacture, supply, hold, import, export and transport Cannabis and derivative products. ICC expects that Lesotho will act as a staging ground for access to larger African markets, including its neighbour South Africa and its population of over 55 million.

Canna Colombia Holdings Inc

In June, the firm entered into a letter of intent to acquire a 100% of Canna Colombia Holdings Inc, formerly Cannabis Medical Group SAS, a Columbian entity that holds licences to cultivate, produce, hold, sell and export Cannabis and its by-products.

Aricannabis BioTech Corp

In August, International Cannabis announced a definitive agreement with Aricannabis BioTech Corp to acquire 100% of Aricannabis's shares.

Aricannabis works on an exclusive basis with NuCare Health to provide Cannabis products to more than 2,800 independent and corporate pharmacies across South Africa.

EU Cannabis Corp.

In June, ICC struck a  definitive agreement with EU Cannabis Corp to acquire 100% of EU Cannabis's shares. The latter has an option to acquire a 90% working interest (WI) in industrial hemp licences held by Cannatec Greece A.E.

Cannatech currently holds three licences covering a total of 16 acres situated within the Greek prefecture of Imathia.

Shares in Toronto eased 1.67% to $0.59.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
A visual representation of a drug candidate working in a dog
January 28 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
data graphic
Fri
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use